Behandling og diagnostik af tuberkulose: fremad med små skridt

Ase Bengård Andersen; Troels Lillebæk; Didi Bang; Julie Prahl

Behandling og diagnostik af tuberkulose: fremad med små skridt

Ase Bengård Andersen, Troels Lillebæk, Didi Bang, Julie Prahl

1 Citationer (Scopus)

Abstract

Development of new drugs for the treatment of drug sensitive and drug resistent tuberculosis is badly needed. Substantial progress has been made in the field and presently six new drug components are in clinical phase I and II trials. Drugs approved for other indications e.g. newer fluoroquinolones and oxazolidinones are also being assessed in human phase II and III trials. Efforts are made to develop easy-to-handle diagnostic tools that will allow early detection of potential MDR or XDR cases. The Xpert RIF/MTB is a prototype of such an invention. At long last the field is moving slowly forward.

Bidragets oversatte titel	[Treatment and diagnostisc of tuberculosis: moving slowly forward.]
Originalsprog	Dansk
Tidsskrift	Ugeskrift for Laeger
Vol/bind	173
Udgave nummer	12
Sider (fra-til)	897-899
Antal sider	3
ISSN	0041-5782
Status	Udgivet - 21 mar. 2011

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Citationsformater

@article{538f6d3ba3d141e2b89852884dc54623,

title = "Behandling og diagnostik af tuberkulose: fremad med sm{\aa} skridt",

abstract = "Development of new drugs for the treatment of drug sensitive and drug resistent tuberculosis is badly needed. Substantial progress has been made in the field and presently six new drug components are in clinical phase I and II trials. Drugs approved for other indications e.g. newer fluoroquinolones and oxazolidinones are also being assessed in human phase II and III trials. Efforts are made to develop easy-to-handle diagnostic tools that will allow early detection of potential MDR or XDR cases. The Xpert RIF/MTB is a prototype of such an invention. At long last the field is moving slowly forward.",

author = "Andersen, {Ase Beng{\aa}rd} and Troels Lilleb{\ae}k and Didi Bang and Julie Prahl",

year = "2011",

month = mar,

day = "21",

language = "Dansk",

volume = "173",

pages = "897--899",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "12",

}

TY - JOUR

T1 - Behandling og diagnostik af tuberkulose: fremad med små skridt

AU - Andersen, Ase Bengård

AU - Lillebæk, Troels

AU - Bang, Didi

AU - Prahl, Julie

PY - 2011/3/21

Y1 - 2011/3/21

N2 - Development of new drugs for the treatment of drug sensitive and drug resistent tuberculosis is badly needed. Substantial progress has been made in the field and presently six new drug components are in clinical phase I and II trials. Drugs approved for other indications e.g. newer fluoroquinolones and oxazolidinones are also being assessed in human phase II and III trials. Efforts are made to develop easy-to-handle diagnostic tools that will allow early detection of potential MDR or XDR cases. The Xpert RIF/MTB is a prototype of such an invention. At long last the field is moving slowly forward.

AB - Development of new drugs for the treatment of drug sensitive and drug resistent tuberculosis is badly needed. Substantial progress has been made in the field and presently six new drug components are in clinical phase I and II trials. Drugs approved for other indications e.g. newer fluoroquinolones and oxazolidinones are also being assessed in human phase II and III trials. Efforts are made to develop easy-to-handle diagnostic tools that will allow early detection of potential MDR or XDR cases. The Xpert RIF/MTB is a prototype of such an invention. At long last the field is moving slowly forward.

M3 - Tidsskriftartikel

SN - 0041-5782

VL - 173

SP - 897

EP - 899

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 12

ER -

Behandling og diagnostik af tuberkulose: fremad med små skridt

Abstract

FN’s Verdensmål

Fingeraftryk

Citationsformater